全球领先的数字病理软件提供商Proscia近日宣布，成功在C+轮融资中筹集了900万美元，使得该轮融资的总金额达到了4600万美元。此轮融资由知名投资机构Highline Capital Management和Triangle Peak Partners领投，包括Alpha Intelligence Capital、Scale Venture Partners以及Hitachi Ventures等在内的现有投资者也积极参与了投资。
Proscia表示，此次筹集的资金将被用于推动公司的商业扩张，特别是在生命科学和诊断实验室领域，进一步开发其人工智能应用程序。这一举措预示着Proscia将在AI驱动的病理学研究和临床实践中迈出更坚实的一步，有望为医疗行业带来更为精准和高效的诊断解决方案。
Proscia的AI病理学云平台已经在业界引起了广泛关注，其创新技术有望重塑病理学的未来。通过将人工智能与数字病理学相结合，Proscia的平台能够提高病理学家的工作效率，同时提升疾病检测的准确性和速度，对于癌症等重大疾病的早期诊断和治疗具有重大意义。
随着新一轮融资的到位，Proscia将进一步巩固其在数字病理学市场的领先地位，同时也将为全球医疗健康领域引入更多基于AI的创新技术，以满足日益增长的精准医疗需求。
英语如下：
**News Title:** “AI Pathology Platform Proscia Secures $9 Million in C+ Round, Accelerating Tech’s Role in Medical Diagnosis”
**Keywords:** Proscia, AI Pathology, $9 Million Funding
**News Content:**
**Title:** AI Pathology Cloud Platform Proscia Completes $9 Million C+ Funding Round to Bolster Tech Adoption in Healthcare
Leading digital pathology software provider Proscia recently announced it has raised $9 million in its C+ funding round, bringing the total for this round to $46 million. The round was led by prominent investors Highline Capital Management and Triangle Peak Partners, with participation from existing investors, including Alpha Intelligence Capital, Scale Venture Partners, and Hitachi Ventures.
Proscia states that the funds raised will be used to fuel the company’s commercial expansion, particularly in the life sciences and diagnostic laboratory sectors, as well as to further develop its artificial intelligence applications. This move signals a stronger commitment by Proscia to advance AI-driven pathology research and clinical practice, potentially revolutionizing diagnostic solutions in the healthcare industry.
Proscia’s AI-powered pathology cloud platform has already garnered significant industry attention. Its innovative technology promises to reshape the future of pathology by combining AI with digital pathology, enhancing pathologists’ efficiency and improving the accuracy and speed of disease detection, which is particularly crucial for early diagnosis and treatment of major diseases like cancer.
With the new funding, Proscia solidifies its position as a leader in the digital pathology market and will introduce more AI-driven innovations to the global healthcare sector, addressing the growing demand for precision medicine.
【来源】https://venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/
Views: 5